Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

THAR

Tharimmune (THAR)

Tharimmune Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:THAR
DatumZeitQuelleÜberschriftSymbolFirma
22/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
14/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
09/05/202414h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:THARTharimmune Inc
11/03/202421h30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:THARTharimmune Inc
11/03/202421h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
23/02/202414h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:THARTharimmune Inc
08/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
12/12/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
11/12/202312h15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:THARTharimmune Inc
27/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
17/11/202323h24Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:THARTharimmune Inc
17/11/202322h22Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:THARTharimmune Inc
17/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
16/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
10/11/202301h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:THARTharimmune Inc
10/11/202301h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:THARTharimmune Inc
07/11/202323h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:THARTharimmune Inc
07/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
07/11/202318h29Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:THARTharimmune Inc
06/11/202323h12Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:THARTharimmune Inc
02/11/202321h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:THARTharimmune Inc
24/10/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:THARTharimmune Inc
29/09/202322h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:THARTharimmune Inc
 Showing the most relevant articles for your search:NASDAQ:THAR